Insulin-Like Growth Factor Inhibition In Lung Cancer

Oncology Times Broadcast News with the Audio Journal of Oncology

Reporting from: 10th European Congress Perspectives in Lung Cancer, Brussels March 6-7, 2009 and Journal of Clinical Oncology

Insulin-Like Growth Factor Inhibition In Lung Cancer

Silvia Novello, and Giorgio Scagliotti from the University of Turin about harnessing insulin-like growth factor receptor inhibition in a phase II study which has shown clinical activity of figitumomab at least as significant as inhibitors of other growth factors already being used in cancer.